Lean patients with fatty liver disease have higher mortality rate

Despite being of a healthier weight, lean patients with nonalcoholic fatty liver disease (NAFLD) have a higher overall mortality rate than patients with NAFLD who are overweight or obese, according to new research presented today at Digestive Disease Week® (DDW). In addition to finding higher mortality rates, an international team of researchers found that lean patients [a body mass index (BMI) less than 25] with NAFLD were more likely to be male, non-Caucasian and to have lower rates of chronic conditions, such as diabetes and hypertension.

"Our comparison of lean patients and their overweight or obese counterparts gives us clues about risk factors for this disease that go beyond a person's weight," said Paul Angulo, MD, section chief of hepatology in the division of digestive diseases and nutrition at the University of Kentucky Medical Center. "These findings have implications both for future research and for current standards of care. We must not assume that patients of relatively healthy weight can't have ."

The retrospective study is the first of its kind in detailing the characteristics of a large number of lean patients with NAFLD. The study examined more than 20 years' worth of clinical and laboratory data of more than 1,000 patients with biopsy-confirmed NAFLD. Lean patients had an average BMI of 23 and the non-lean group had an average BMI of 33.

The lean group had significantly less insulin resistance as well as lower levels of a called alanine aminotransferase (ALT) that correlates with liver damage. And while lean patients had a lower degree of fatty deposits on the liver and less advanced fibrosis, these patients showed more severe inflammation of the liver.

Of the 1,090 patients, liver biopsy was done before 2005 in 483 patients. In this subgroup, nine of the 32 (28 percent) lean patients died compared to 62 of the 451 (14 percent) overweight or obese patients. In examining the specific cause of mortality, researchers did not find any differences between the two groups.

"About 30 percent of the U.S. population suffers from NAFLD, and the prevalence of this condition is increasing. Although we often associate fatty with , these results suggest that possible signs of liver disease secondary to NAFLD in lean patients should be taken very seriously," said Dr. Angulo.

Dr. Angulo and his team plan to expand on their findings about this specific patient population by examining data beyond BMI, including fat distribution and differences in cell signaling proteins, such as cytokine and adipokine profiles. They also plan to include patients who have not yet had a .

Dr. Paul Angulo will present data from the study "Characteristics and long-term prognosis of lean patients with ," abstract 379, on Sunday, May 4, at 2:45 p.m. CT, in room S405A of McCormick Place.

Provided by Digestive Disease Week

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Weight-loss surgery can reduce liver damage

May 04, 2014

Bariatric surgery, which is best known for its ability to help patients lose substantial weight, can also result in significant improvement in nonalcoholic fatty liver disease (NAFLD), according to new research presented ...

Nonalcoholic fatty liver disease linked to CKD in T1DM

Apr 09, 2014

(HealthDay)—For patients with type 1 diabetes, nonalcoholic fatty liver disease (NAFLD) is independently associated with the risk of incident chronic kidney disease (CKD), according to a study published ...

Weight loss surgery alters fatty liver disease genes

Aug 06, 2013

Research has shown that weight loss surgery can benefit obese individuals in ways that go beyond shedding pounds, for example by causing early remission of type 2 diabetes. Now scientists have found that the surgery can also ...

NAFLD increases the risk of early atherosclerotic lesions

Apr 26, 2013

A study presented today at the International Liver Congress 2013 – which evaluated the relationship between non-alcoholic fatty liver disease (NAFLD), early predictors of atherosclerosis and the 10-year Framingham risk ...

Estrogen protects women with NASH from severe liver fibrosis

Oct 29, 2013

New research suggests that estrogen protects women with nonalcoholic steatohepatitis (NASH) from severe liver fibrosis. According to the study published online in Hepatology, a journal of the American Association for the St ...

Recommended for you

Africans in New York complain of Ebola stigma

5 hours ago

Members of the west African community in New York complained Wednesday that their children were being bullied at school and businesses were losing money because of hysteria over Ebola.

Ebola expert says China at risk, seeks Japan aid

5 hours ago

A scientist who helped to discover the Ebola virus says he is concerned that the disease could spread to China given the large numbers of Chinese workers traveling to and from Africa.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.